XML 36 R23.htm IDEA: XBRL DOCUMENT v3.20.1
Derivative Financial Instruments
3 Months Ended
Mar. 31, 2020
Derivative Instruments And Hedging Activities Disclosure [Abstract]  
Derivative Financial Instruments

15. Derivative Financial Instruments

 

The Company manages changes in market conditions related to interest on debt obligations and foreign currency exposures by entering into derivative instruments, including interest rate and foreign currency swap agreements. All derivative instruments are recognized as either assets or liabilities on the balance sheet at fair value at the end of each period. The Company determines the fair value of financial instruments using quoted market prices whenever available. When quoted market prices are not available for various types of financial instruments (such as forwards, options and swaps), the Company uses standard models with market-based inputs, which take into account the present value of estimated future cash flows and the ability of Altra or the financial counterparty to perform. For interest rate swaps, the significant inputs to these models are interest rate curves for discounting future cash flows that are adjusted for credit risk. For forward foreign currency contracts, the significant inputs are interest rate curves for discounting future cash flows, and exchange rate curves of the foreign currency for translating future cash flows. For designated hedging relationships, the Company formally documents the hedging relationship consistent with the requirements of ASC 815, Derivatives

The following table summarizes outstanding swaps that the Company has recorded at March 31, 2020.

 

 

 

 

 

Initial US$

 

 

 

 

 

 

 

 

 

 

 

 

 

Date

 

Derivative

 

Notional

 

 

 

 

 

 

 

 

 

 

 

 

 

Entered

 

Financial

 

Amount

 

 

Fixed Rate

 

Floating Leg

 

Fixed Rate

 

Floating Leg

 

Settlement

 

Effective

into

 

Instrument

 

(millions)

 

 

(swap counterparty)

 

(swap counterparty)

 

(Company)

 

(Company)

 

Dates

 

Period of Swap

12/4/2018

 

Interest rate

swap

 

$

600.0

 

 

4.8255%

 

Variable rate 1-

month USD

LIBOR plus 2%

 

N/A

 

1 Month

USD-

LIBOR-

BBA

plus 2%

 

Monthly on the last

   business day of each

   month commencing

   with December 31,

   2018 in accordance

   with Modified

   Following Business

   Day Convention

 

12/4/2018 - 9/29/2023

 

Cross Currency Interest Rate Swaps

In December 2018, the Company entered into cross-currency swap agreements to hedge its net investment in Euro-denominated assets against future volatility in the exchange rate between the U.S. dollar and the Euro. By doing so, the Company synthetically converted a portion of its U.S. dollar-based long-term debt into Euro-denominated long-term debt. The agreements originally had a five-year maturity at notional amounts declining from $600.0 million to $360.0 million over the contract period. The terms of the swap agreements provided for the Company to receive net interest payments at a fixed rate of 4.8255% and pay Euros at rates ranging from 2.19% to 2.315%. At inception, the cross-currency swaps were designated as net investment hedges.

For net investment hedges, changes in the fair value of the effective portion of the derivatives’ gains or losses are reported as foreign currency translation gains or losses in accumulated other comprehensive income (loss) (“AOCIL”). The gains or losses on derivative instruments reported in AOCIL are reclassified to earnings in the period in which earnings are affected by the underlying item, such as a disposal or substantial liquidations of the entities being hedged.

During the first quarter of 2020, the global economy declined substantially due to the impact of COVID-19. This decline resulted in a significant increase in the value of the U.S. dollar. The appreciation of the U.S. dollar resulted in the Company’s cross currency interest rate swaps being substantially in-the-money. Given the increased cash value of the hedges and the Company’s overall desire to strengthen its cash position, the Company terminated the cross-currency interest rate swaps during the first quarter of 2020. The Company received the cash value of the cross-currency interest rate swaps of approximately $56.2 million upon termination. In addition, the Company paid the interest owed and received the interest due, resulting in the recognition of approximately $3.3 million in net interest income and paid termination fees of approximately $0.9 million. As a result of the termination of the cross-currency interest rate swap, the Company recorded a gain in AOCIL of approximately $31.3 million, net of $9.9 million of tax, compared to $19.8 million, net of $3.6 million of tax, during the quarter ended March 31, 2020, and year to date period ended December 31, 2019, respectively.

 

 

 

 

 

 

 

 

 

 

 

 

March 31, 2020

 

 

December 31, 2019

 

Description (in millions)

 

Gain/(Loss) Recognized in AOCI

 

Cross currency swap agreements, net of tax

 

$

31.3

 

 

$

19.8

 

 

Interest Rate Swaps  

In January 2017, the Company entered into an interest rate swap agreement to fix the variable interest rate payable on a portion of its outstanding borrowings. This interest rate swap matured on January 31, 2020.

In December 2018, the Company entered into an interest rate swap agreement to manage the cash flow risk caused by interest rate changes on the forecasted interest payments expected to occur related to a portion of its outstanding borrowings under the Altra Credit Agreement for a notional value of $600 million at 4.8255%.

 

The interest rate swap agreement is designed to manage exposure to interest rates on the Company’s variable rate indebtedness and is recognized on the balance sheet at fair value. The Company has designated this interest rate swap agreement as a cash flow hedge. Changes in the fair value of the swap will be recognized in other comprehensive income until the hedged items are recognized in earnings. The Company recorded a loss in AOCIL of approximately $11.7 million, net of a $3.7 million tax benefit, and $9.8 million, net of a $1.7 million tax benefit, during the quarter ended March 31, 2020, and year to date period ended December 31, 2019, respectively.

 

The following table summarizes the location and fair value, using Level 2 inputs (see Note 6 for a description of the fair value levels), of the Company's derivatives designated and not designated as hedging instruments in the unaudited condensed consolidated balance sheets (in millions).

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance Sheet Location

 

March 31, 2020

 

 

December 31, 2019

 

Designated as hedging instruments:

 

 

 

 

 

 

 

 

 

 

Cross currency swap agreements

 

Other long-term (assets)/liabilities

 

$

 

 

$

(15.0

)

Interest rate swap agreement

 

Other long-term (assets)

 

 

 

 

 

(0.0

)

Interest rate swap agreement

 

Other long-term liabilities

 

 

34.4

 

 

 

19.0

 

 

 

 

 

$

34.4

 

 

$

4.0